Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Pharmaceutical Advertising topic
No spam. Unsubscribe anytime.
Cable industry warns ad ban and chatbot language could impose undue burdens on operators
Summary
The Minnesota Cable Communications Association urged removal or clarification of a proposed prescription‑drug television ad ban and asked that enforcement target pharmaceutical manufacturers rather than cable operators; the group also urged caution on chatbot provisions to avoid sweeping in routine business tools.
Melissa Wolf, executive director of the Minnesota Cable Communications Association, told the conference committee that language in the omnibus bill prohibiting television advertising for prescription drugs raises constitutional and operational concerns for cable operators.
Wolf said the intent may be to regulate pharmaceutical companies, not carriers, and that enforcement and compliance responsibility should rest with manufacturers, advertisers or their agents rather than cable companies that run ad space. She noted cable operators are not positioned to determine which drugs are covered by specific state programs and that placing compliance obligations on carriers would create untenable operational burdens and litigation risk.
On separate provisions related to minor access to chatbots, Wolf recommended careful drafting to avoid unintentionally sweeping in routine customer‑service tools businesses rely on for account support. She urged the legislature to study the rapidly evolving landscape and craft precise language.
The committee recorded no follow‑up questions in the transcript after this testimony.
